Drug Database
Back to search

Norway· NO-ID_146E2349-85AE-4AB1-AD75-842452231F8C

Evista

A raloxifene product containing raloxifene hydrochloride, registered in Norway by Substipharm. The same ATC class is registered in 19 of our 19 countries.

ATC G03XC01

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedEvistaATCG03XC01REGISTER NO.NO-ID_146E2349-85AE-4…PACKS LISTED2CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about raloxifene hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Raloxifene is registered in 19 of 19 countries.

Countries holding a registration under ATC G03XC01 (raloxifene), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 11 of them publish a price we can compare per daily dose
Search raloxifene products by name

Raloxifene · ATC G03XC01

19 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of raloxifene costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $0.44 in France to $1.28 in Switzerland — a ×2.9 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Raloxifene · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.28
  • ES Spain$0.84
  • IT Italy$0.70
  • FR France$0.44
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Raloxifene Hydrochloride
Manufacturer
Substipharm
Country
Norway (NO)
ATC code
G03XC01
ATC class
Raloxifene
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 2

  • no_merkevare_id
    ID_146E2349-85AE-4AB1-AD75-842452231F8C
  • no_varenummer
    309903
    28

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

183 interactions on record for raloxifene.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check raloxifene against other medicinesHow interaction checks work

Raloxifene · interactions on record

183 records

  • 8 severe
  • 12 moderate
  • 6 minor
  • 157 info

Most severe, free to view

  • Tranexamic acidB02AA02severe
  • BexaroteneL01XF03severe
  • CarfilzomibL01XG02severe
  • BexarotenL01XX25severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Raloxifene in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All raloxifene products

Authorised across Europe · EMA

The same active substance is authorised in 15 EEA countries. Names it is sold under:

  • Austria · Raloxifen Stada
  • Cyprus · Ostiral
  • Germany · Raloxifen Al, Raloxifen-Hcl Hexal
  • Spain · Raloxifeno Aurovitas, Raloxifeno Cinfamed
  • France · Raloxifene Arrow, Raloxifene Biogaran
  • United Kingdom (Northern Ireland) · Evirex, Ostiral
  • Greece · Ostiral
  • Hungary · Clastellos, Raloxibone
  • Iceland · Evista, Optruma
  • Italy · Raloxifene Sandoz
  • Liechtenstein · Evista, Optruma
  • Netherlands · Raloxifeenhydrochloride Brillpharma, Raloxifene Hydrochloride Aurobindo
  • Portugal · Raloxifeno Ciclum, Raloxifeno Exeltis
  • Romania · Raloxifen Arena
  • Sweden · Raloxifen Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/6624aab2-d46a-4aa7-be79-def312f59e89
GET /v1/drugs/6624aab2-d46a-4aa7-be79-def312f59e89?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Raloksifen",
  "merkevare_id": "ID_146E2349-85AE-4AB1-AD75-842452231F8C",
  "name_form_strength": "Evista tab 60 mg",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about raloxifene.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console